Dalcetrapib in High-Risk Patients with Type 2 Diabetes Mellitus and/or Metabolic Syndrome

Abstract

Peer reviewed

Michael H. Davidson, Anton F.H. Stalenhoef, Jennifer G. Robinson, Regina Duttlinger-Maddux, David Kallend and Harold Bays

Journal of clinical lipidology, Vol.3(3), pp.223-223

05/2009

DOI: 10.1016/j.jacl.2009.04.026

View Online

Title: Subtitle: Dalcetrapib in High-Risk Patients with Type 2 Diabetes Mellitus and/or Metabolic Syndrome
Creators: Michael H. Davidson - Chicago, IL
Anton F.H. Stalenhoef - Chicago, IL
Jennifer G. Robinson
Regina Duttlinger-Maddux - Chicago, IL
David Kallend - Chicago, IL
Harold Bays - Chicago, IL
Resource Type: Abstract
Publication Details: Journal of clinical lipidology, Vol.3(3), pp.223-223
DOI: 10.1016/j.jacl.2009.04.026
ISSN: 1933-2874
eISSN: 1876-4789
Language: English
Date published: 05/2009
Academic Unit: Epidemiology; Fraternal Order of Eagles Diabetes Research Center
Record Identifier: 9984364519402771

5 Record Views